Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 312 JPY -0.46%
Market Cap: 32.5B JPY

Net Margin
Fuji Pharma Co Ltd

6.5%
Current
9%
Average
5.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.5%
=
Net Income
3.2B
/
Revenue
48.8B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
JP
Fuji Pharma Co Ltd
TSE:4554
32B JPY
7%
US
Eli Lilly and Co
NYSE:LLY
699.1B USD
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
373.4B USD
24%
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK
35%
CH
Roche Holding AG
SIX:ROG
211.7B CHF
14%
CH
Novartis AG
SIX:NOVN
186.7B CHF
24%
UK
AstraZeneca PLC
LSE:AZN
164.7B GBP
14%
US
Merck & Co Inc
NYSE:MRK
193.3B USD
27%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
-126%
US
Pfizer Inc
NYSE:PFE
133.5B USD
13%

Fuji Pharma Co Ltd
Glance View

Market Cap
32B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
1 741.88 JPY
Undervaluation 25%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.5%
=
Net Income
3.2B
/
Revenue
48.8B
What is the Net Margin of Fuji Pharma Co Ltd?

Based on Fuji Pharma Co Ltd's most recent financial statements, the company has Net Margin of 6.5%.

Back to Top